Pulmonary Alveolar Proteinosis: Is the Focus in Treatment Shifted From 'Physical' to 'Pharmacological'?

Nishioka Y

Open source

DOI
10.1002/resp.70323
Published
2026 Sep 24
Container
Respirology (Carlton, Vic.)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/resp.70323,
  title = {Pulmonary Alveolar Proteinosis: Is the Focus in Treatment Shifted From 'Physical' to 'Pharmacological'?},
  author = {Nishioka Y},
  year = {2026},
  journal = {Respirology (Carlton, Vic.)},
  doi = {10.1002/resp.70323},
  url = {https://doi.org/10.1002/resp.70323}
}

RIS

TY  - JOUR
TI  - Pulmonary Alveolar Proteinosis: Is the Focus in Treatment Shifted From 'Physical' to 'Pharmacological'?
AU  - Nishioka Y
PY  - 2026
JO  - Respirology (Carlton, Vic.)
DO  - 10.1002/resp.70323
UR  - https://doi.org/10.1002/resp.70323
ER  - 

APA

Y, N. (2026). Pulmonary Alveolar Proteinosis: Is the Focus in Treatment Shifted From 'Physical' to 'Pharmacological'?. Respirology (Carlton, Vic.). https://doi.org/10.1002/resp.70323

Source records